Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ingrid Murillo Jelsbak
Biofabri
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
240
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Live-Attenuated M. Tuberculosis Vaccine, MTBVAC, in Adults with or Without M. Tuberculosis Sensitization: A Phase 1b/2a Randomized, Controlled, Double-Blind, Dose-Escalation Trial
Number of pages: 29
Posted: 02 Oct 2023
Angelique Kany Kany Luabeya
,
Virginie Rozot
,
Claire Imbratta
,
Frances Ratangee
,
Justin Shenje
,
Michèle Tameris
,
Simon C. Mendelsohn
,
Hennie Geldenhuys
,
Michelle Fisher
,
Munyaradzi Musvosvi
,
Humphrey Mulenga
,
Nicole Bilek
,
Simbarashe Mabwe
, Ingrid Murillo Jelsbak,
Esteban Rodríguez
,
Eugenia Puentes
,
Juana Doce
,
Nacho Aguilo
,
Carlos Martin
,
Cadwill Pillay
,
Dereck Tait
,
Lewis Schrager
,
Marisa Russell
,
Kathryn Rutkowski
,
Devin Hunt
,
Thomas J. Scriba
and
Mark Hatherill
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads
124
(580,653)
View PDF
Download
Abstract:
tuberculosis, MTBVAC, Vaccine, safety, immunogenicity
2.
Safety, Reactogenicity, and Immunogenicity of Mtbvac in Infants: A Phase 2a Randomized, Double-Blind, Dose-Defining Trial in a Tb Endemic Setting
Number of pages: 22
Posted: 31 May 2024
Michèle Tameris
,
Virginie Rozot
,
Claire Imbratta
,
Hennie Geldenhuys
,
Simon C. Mendelsohn
,
Angelique Kany Kany Luabeya
,
Justin Shenje
,
Nicolette Tredooux
,
Michelle Fisher
,
Humphrey Mulenga
,
Nicole Bilek
,
Carly Young
,
Ashley Veldsman
,
Natasja Botes
,
Jelle Thole
,
Bernard Fritzell
,
Rajat Mukherjee
, Ingrid Murillo Jelsbak,
Esteban Rodrigues
,
Eugenia Puentes
,
Juana Doce
,
Dessislava Marinova
,
Jesus Gonzalo-Asensio
,
Nacho Aguilo
,
Carlos Martin
,
Thomas J. Scriba
and
Mark Hatherill
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Mukherjee Consultants, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads
116
(613,149)
View PDF
Download
Abstract:
tuberculosis, newborns, vaccine, BCG, MTBVAC
Feedback